154 related articles for article (PubMed ID: 19082465)
41. Vascular endothelial growth factor is a strong predictor of early distant recurrences in a prospective study of premenopausal women with lymph-node negative breast cancer.
Linderholm BK; Gruvberger-Saal S; Fernö M; Bendahl PO; Malmström P
Breast; 2008 Oct; 17(5):484-91. PubMed ID: 18508268
[TBL] [Abstract][Full Text] [Related]
42. The Rac activator Tiam1 and Ras-induced oncogenesis.
Strumane K; Rygiel TP; Collard JG
Methods Enzymol; 2006; 407():269-81. PubMed ID: 16757331
[TBL] [Abstract][Full Text] [Related]
43. Prognostic significance of molecular classification of breast invasive ductal carcinoma.
Muñoz M; Fernández-Aceñero MJ; Martín S; Schneider J
Arch Gynecol Obstet; 2009 Jul; 280(1):43-8. PubMed ID: 19082617
[TBL] [Abstract][Full Text] [Related]
44. Apocrine carcinomas of the breast in Turkish women: hormone receptors, c-erbB-2 and p53 immunoexpression.
Kaya H; Bozkurt SU; Erbarut I; Djamgoz MB
Pathol Res Pract; 2008; 204(6):367-71. PubMed ID: 18342452
[TBL] [Abstract][Full Text] [Related]
45. Obesity and risk of the less commonly diagnosed subtypes of breast cancer.
Stark A; Schultz D; Kapke A; Nadkarni P; Burke M; Linden M; Raju U
Eur J Surg Oncol; 2009 Sep; 35(9):928-35. PubMed ID: 19121564
[TBL] [Abstract][Full Text] [Related]
46. Expression and molecular characterization of alternative transcripts of the ARHGEF5/TIM oncogene specific for human breast cancer.
Debily MA; Camarca A; Ciullo M; Mayer C; El Marhomy S; Ba I; Jalil A; Anzisi A; Guardiola J; Piatier-Tonneau D
Hum Mol Genet; 2004 Feb; 13(3):323-34. PubMed ID: 14662653
[TBL] [Abstract][Full Text] [Related]
47. The guanine nucleotide exchange factor Tiam1 increases colon carcinoma growth at metastatic sites in an orthotopic nude mouse model.
Minard ME; Herynk MH; Collard JG; Gallick GE
Oncogene; 2005 Apr; 24(15):2568-73. PubMed ID: 15735692
[TBL] [Abstract][Full Text] [Related]
48. Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma.
Faratian D; Munro A; Twelves C; Bartlett JM
Histopathology; 2009 Jan; 54(2):254-7. PubMed ID: 19207951
[TBL] [Abstract][Full Text] [Related]
49. The guanine nucleotide exchange factor Tiam1 affects neuronal morphology; opposing roles for the small GTPases Rac and Rho.
Leeuwen FN; Kain HE; Kammen RA; Michiels F; Kranenburg OW; Collard JG
J Cell Biol; 1997 Nov; 139(3):797-807. PubMed ID: 9348295
[TBL] [Abstract][Full Text] [Related]
50. Endogenous NIS expression in triple-negative breast cancers.
Renier C; Yao C; Goris M; Ghosh M; Katznelson L; Nowles K; Gambhir SS; Wapnir I
Ann Surg Oncol; 2009 Apr; 16(4):962-8. PubMed ID: 19184238
[TBL] [Abstract][Full Text] [Related]
51. Tiam1-deficiency impairs mammary tumor formation in MMTV-c-neu but not in MMTV-c-myc mice.
Strumane K; Rygiel T; van der Valk M; Collard JG
J Cancer Res Clin Oncol; 2009 Jan; 135(1):69-80. PubMed ID: 18592271
[TBL] [Abstract][Full Text] [Related]
52. Rabbit monoclonal antibodies show higher sensitivity than mouse monoclonals for estrogen and progesterone receptor evaluation in breast cancer by immunohistochemistry.
Rocha R; Nunes C; Rocha G; Oliveira F; Sanches F; Gobbi H
Pathol Res Pract; 2008; 204(9):655-62. PubMed ID: 18565685
[TBL] [Abstract][Full Text] [Related]
53. Combined analysis of Rac1, IQGAP1, Tiam1 and E-cadherin expression in gastric cancer.
Walch A; Seidl S; Hermannstädter C; Rauser S; Deplazes J; Langer R; von Weyhern CH; Sarbia M; Busch R; Feith M; Gillen S; Höfler H; Luber B
Mod Pathol; 2008 May; 21(5):544-52. PubMed ID: 18246045
[TBL] [Abstract][Full Text] [Related]
54. Cloning and characterization of T-cell lymphoma invasion and metastasis 2 (TIAM2), a novel guanine nucleotide exchange factor related to TIAM1.
Chiu CY; Leng S; Martin KA; Kim E; Gorman S; Duhl DM
Genomics; 1999 Oct; 61(1):66-73. PubMed ID: 10512681
[TBL] [Abstract][Full Text] [Related]
55. Urokinase-type plasminogen activator and plasminogen-activator-inhibitor type 1 predict metastases in good prognosis breast cancer patients.
De Cremoux P; Grandin L; Diéras V; Savignoni A; Degeorges A; Salmon R; Bollet MA; Reyal F; Sigal-Zafrani B; Vincent-Salomon A; Sastre-Garau X; Magdelénat H; Mignot L; Fourquet A;
Anticancer Res; 2009 May; 29(5):1475-82. PubMed ID: 19443353
[TBL] [Abstract][Full Text] [Related]
56. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
Li XF; Yan PJ; Shao ZM
Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
[TBL] [Abstract][Full Text] [Related]
57. Feasibility of measuring the prognostic factors uPA and PAI-1 in core needle biopsy breast cancer specimens.
Thomssen C; Harbeck N; Dittmer J; Abraha-Spaeth SR; Papendick N; Paradiso A; Lisboa B; Jaenicke F; Schmitt M; Vetter M
J Natl Cancer Inst; 2009 Jul; 101(14):1028-9. PubMed ID: 19535782
[No Abstract] [Full Text] [Related]
58. Oestrogen receptor-beta1 but not oestrogen receptor-betacx is of prognostic value in apocrine carcinoma of the breast.
Honma N; Saji S; Kurabayashi R; Aida J; Arai T; Horii R; Akiyama F; Iwase T; Harada N; Younes M; Toi M; Takubo K; Sakamoto G
APMIS; 2008 Oct; 116(10):923-30. PubMed ID: 19132986
[TBL] [Abstract][Full Text] [Related]
59. EGFR as paradoxical predictor of chemosensitivity and outcome among triple-negative breast cancer.
Nogi H; Kobayashi T; Suzuki M; Tabei I; Kawase K; Toriumi Y; Fukushima H; Uchida K
Oncol Rep; 2009 Feb; 21(2):413-7. PubMed ID: 19148516
[TBL] [Abstract][Full Text] [Related]
60. [Occult multicentric breast cancer].
Vtorushin SV; Zab'ialova MV; Glushchenko SA; Perel'muter VM; Slonimskaia EM
Vopr Onkol; 2009; 55(1):38-41. PubMed ID: 19435197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
